Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription Articles published in Diabetes Retrieve available abstracts of 124 articles: HTML format

Single Articles

April 2024
1. EVANS-MOLINA C
   The Ailing beta-Cell in Diabetes: Insights From a Trip to the ER: The 2023 Outstanding Scientific Achievement Award Lecture.
   Diabetes. 2024;73:545-553.
   PubMed     Abstract available
   
   
   
2. DRAWSHY Z, Neiman D, Fridlich O, Peretz A, et al
   DNA Methylation-Based Assessment of Cell Composition in Human Pancreas and Islets.
   Diabetes. 2024;73:554-564.
   PubMed     Abstract available
   
   
   March 2024
3. KIM YK, Kim YR, Wells KL, Sarbaugh D, et al
   PTPN2 Regulates Metabolic Flux to Affect beta-Cell Susceptibility to Inflammatory Stress.
   Diabetes. 2024;73:434-447.
   PubMed     Abstract available
   
   
   February 2024
4. KASINATHAN D, Guo Z, Sarver DC, Wong GW, et al
   Cell-surface ZnT8 antibody prevents and reverses autoimmune diabetes in mice.
   Diabetes. 2024 Feb 22:db230568. doi: 10.2337/db23-0568.
   PubMed     Abstract available
   
   
   
5. CALLEBAUT A, Guyer P, Derua R, Buitinga M, et al
   CD4+ T cells from individuals with type 1 diabetes respond to a novel class of deamidated peptides formed in pancreatic islets.
   Diabetes. 2024 Feb 22:db230588. doi: 10.2337/db23-0588.
   PubMed     Abstract available
   
   
   January 2024
6. CALLEBAUT A, Guyer P, Baker RL, Gallegos JB, et al
   An Insulin-Chromogranin A Hybrid Peptide activates DR11 restricted T cells in human type 1 diabetes.
   Diabetes. 2024 Jan 31:db230622. doi: 10.2337/db23-0622.
   PubMed     Abstract available
   
   
   
7. CIOU JJ, Chien MW, Hsu CY, Liu YW, et al
   Excess Salt Intake Activates IL-21-dominant Autoimmune Diabetogenesis via A Saltregulated Ste20-related Proline/alanine-rich Kinase in CD4 T Cells.
   Diabetes. 2024 Jan 19:db230599. doi: 10.2337/db23-0599.
   PubMed     Abstract available
   
   
   
8. WYATT RC, Grace SL, Brigatti C, Marzinotto I, et al
   Improved specificity of glutamate decarboxylase 65 autoantibody measurement using luciferase-based immunoprecipitation system (LIPS) assays.
   Diabetes. 2024 Jan 17:db230550. doi: 10.2337/db23-0550.
   PubMed     Abstract available
   
   
   November 2023
9. KUGATHASAN L, Sridhar VS, Lovblom LE, Matta S, et al
   Interactive effects of Empagliflozin and Hyperglycemia on Urinary Amino Acids in Individuals with Type 1 Diabetes.
   Diabetes. 2023 Nov 28:db230694. doi: 10.2337/db23-0694.
   PubMed     Abstract available
   
   
   
10. LAI SWT, Hernandez-Castillo C, De Jesus Lopez Gonzalez E, Zoukari T, et al
    Methylglyoxal adducts are prognostic biomarkers for diabetic kidney disease in patients with type 1 diabetes.
    Diabetes. 2023 Nov 15:db230277. doi: 10.2337/db23-0277.
    PubMed     Abstract available
    
    
    
11. ILONEN J, Kiviniemi M, El-Amir MI, Nygard L, et al
    Increased Frequency of the HLA-DRB1*04:04-DQA1*03-DQB1*03:02 Haplotype among HLA-DQB1*06:02 Positive Children with Type 1 Diabetes.
    Diabetes. 2023 Nov 7:db230387. doi: 10.2337/db23-0387.
    PubMed     Abstract available
    
    
    
12. ELGAMAL RM, Kudtarkar P, Melton RL, Mummey HM, et al
    An Integrated Map of Cell Type-Specific Gene Expression in Pancreatic Islets.
    Diabetes. 2023;72:1719-1728.
    PubMed     Abstract available
    
    
    October 2023
13. ZOU W, Chezhian J, Yu T, Liu W, et al
    Dissecting the roles of the nuclear and mitochondrial genomes in a mouse model of autoimmune diabetes.
    Diabetes. 2023 Oct 17:db230430. doi: 10.2337/db23-0430.
    PubMed     Abstract available
    
    
    
14. XU G, Chen J, Lu B, Sethupathy P, et al
    Verapamil Prevents Decline of IGF-I in Subjects With Type 1 Diabetes and Promotes beta-Cell IGF-I Signaling.
    Diabetes. 2023;72:1460-1469.
    PubMed     Abstract available
    
    
    September 2023
15. OBERHAUSER SS, l'Allemand D, Willems EP, Gozzi T, et al
    The slowing of peripheral nerve conduction velocity in children and adolescents with type 1 diabetes is predicted by glucose fluctuations.
    Diabetes. 2023 Sep 12:db230063. doi: 10.2337/db23-0063.
    PubMed     Abstract available
    
    
    August 2023
16. FOTINO C, Molano RD, Nasr MB, Umland O, et al
    Reversal of experimental autoimmune diabetes with a sCD39/anti-CD3 treatment.
    Diabetes. 2023 Aug 25:db230178. doi: 10.2337/db23-0178.
    PubMed     Abstract available
    
    
    July 2023
17. SASSI G, Licata G, Ventriglia G, Wouters A, et al
    A plasma miR-193b-365 signature combined with age and glycemic status predicts response to Lactococcus lactis-based antigen-specific immunotherapy in new-onset type 1 diabetes.
    Diabetes. 2023 Jul 26:db220852. doi: 10.2337/db22-0852.
    PubMed     Abstract available
    
    
    
18. WRETLIND A, Curovic VR, Suvitaival T, Theilade S, et al
    Ceramides as risk markers for future cardiovascular events and all-cause mortality in long-standing type 1 diabetes.
    Diabetes. 2023 Jul 21:db230052. doi: 10.2337/db23-0052.
    PubMed     Abstract available
    
    
    
19. SCHON M, Zaharia OP, Strassburger K, Kupriyanova Y, et al
    Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 Diabetes Mellitus.
    Diabetes. 2023 Jul 21:db230353. doi: 10.2337/db23-0353.
    PubMed     Abstract available
    
    
    
20. TANG Y, Ang L, Jaiswal M, Dillon BR, et al
    Cardiovascular autonomic neuropathy and risk of kidney function decline in type 1 and type 2 diabetes: findings from the PERL and ACCORD cohorts.
    Diabetes. 2023 Jul 19:db230247. doi: 10.2337/db23-0247.
    PubMed     Abstract available
    
    
    June 2023
21. GITELMAN SE, Evans-Molina C, Guolo A, Mari A, et al
    ss-cell glucose sensitivity to assess changes in ss-cell function in recent onset stage 3 type 1 diabetes.
    Diabetes. 2023 Jun 27:db230196. doi: 10.2337/db23-0196.
    PubMed     Abstract available
    
    
    
22. QURESHI FM, Panzer JK, Poder J, Malek TR, et al
    Immunotherapy With Low-Dose IL-2/CD25 Prevents beta-Cell Dysfunction and Dysglycemia in Prediabetic NOD Mice.
    Diabetes. 2023;72:769-780.
    PubMed     Abstract available
    
    
    
23. ROJAS-CANALES D, Walters SN, Penko D, Cultrone D, et al
    Intracutaneous Transplantation of Islets Within a Biodegradable Temporizing Matrix as an Alternative Site for Islet Transplantation.
    Diabetes. 2023;72:758-768.
    PubMed     Abstract available
    
    
    May 2023
24. POSTIC S, Pfabe J, Sarikas S, Ehall B, et al
    Tracking Ca2+ dynamics in NOD mouse islets during spontaneous diabetes development.
    Diabetes. 2023 May 31:db220952. doi: 10.2337/db22-0952.
    PubMed     Abstract available
    
    
    
25. BODE K, MacDonald T, Stewart T, Mendez B, et al
    Protective Renalase-deficiency in beta cells shapes immune metabolism and function in autoimmune diabetes.
    Diabetes. 2023 May 22:db230030. doi: 10.2337/db23-0030.
    PubMed     Abstract available
    
    
    
26. MONTEFUSCO L, Pastore I, Lunati ME, Fiorina P, et al
    Increased Risk of Diabetes and Diabetic Ketoacidosis Associated With COVID-19.
    Diabetes. 2023;72:560-561.
    PubMed    
    
    
    April 2023
27. HSU CC, Fidler TP, Kanter JE, Kothari V, et al
    Hematopoietic NLRP3 and AIM2 inflammasomes promote diabetes-accelerated atherosclerosis, but increased necrosis is independent of pyroptosis.
    Diabetes. 2023 Apr 21:db220962. doi: 10.2337/db22-0962.
    PubMed     Abstract available
    
    
    
28. JANSEN TJP, Buitinga M, Boss M, Nijhoff MF, et al
    Monitoring beta cell survival after intrahepatic islet transplantation using dynamic exendin PET imaging: a proof-of-concept study in individuals with type 1 diabetes.
    Diabetes. 2023 Apr 17:db220884. doi: 10.2337/db22-0884.
    PubMed     Abstract available
    
    
    March 2023
29. XIE L, Lu W, Zhang Y, Deng L, et al
    Glucose-activated switch regulating insulin analogue secretion enables long-term precise glucose control in type 1 diabetes mice.
    Diabetes. 2023 Mar 13:db220860. doi: 10.2337/db22-0860.
    PubMed     Abstract available
    
    
    January 2023
30. NJEIM R, Braych K, Ghadieh HE, Azar NS, et al
    VEGF-A: A NOVEL MECHANISTIC LINK BETWEEN CYP2C-DERIVED EET AND NOX4 IN DIABETIC KIDNEY DISEASE.
    Diabetes. 2023 Jan 20:db220636. doi: 10.2337/db22-0636.
    PubMed     Abstract available
    
    
    
31. KAWATA S, Kozawa J, Yoneda S, Fujita Y, et al
    Inflammatory Cell Infiltration into Islets without PD-L1 Expression is Associated with the Development of Immune Checkpoint Inhibitor-Related Type 1 Diabetes in Genetically Susceptible Patients.
    Diabetes. 2023 Jan 19:db220557. doi: 10.2337/db22-0557.
    PubMed     Abstract available
    
    
    December 2022
32. PETSIOU A, Vartholomatos G, Tsatsoulis A, Papadopoulos GK, et al
    Comment on Liu et al. Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple beta-Cell Peptides in Type 1 Diabetes. Diabetes 2022;71:722-732.
    Diabetes. 2022;71:e20-e21.
    PubMed    
    
    
    
33. MISRA S, DiMeglio LA
    COVID-19 and Incident Type 1 Diabetes: Deciphering the Associations.
    Diabetes. 2022;71:2480-2482.
    PubMed    
    
    
    
34. PIETROPAOLO M, Hotez P, Giannoukakis N
    Response to Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2- Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656-2663.
    Diabetes. 2022;71:e19.
    PubMed    
    
    
    
35. HSU CK, Lai CC
    Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2-Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656-2663.
    Diabetes. 2022;71:e18.
    PubMed    
    
    
    
36. SYREENI A, Dahlstrom EH, Hagg-Holmberg S, Forsblom C, et al
    Haptoglobin Genotype Does Not Confer a Risk of Stroke in Type 1 Diabetes.
    Diabetes. 2022;71:2728-2738.
    PubMed     Abstract available
    
    
    
37. GOU W, Hua W, Swaby L, Cui W, et al
    Stem Cell Therapy Improves Human Islet Graft Survival in Mice via Regulation of Macrophages.
    Diabetes. 2022;71:2642-2655.
    PubMed     Abstract available
    
    
    November 2022
38. GUO Z, Kasinathan D, Merriman C, Nakayama M, et al
    A Cell-Surface Autoantibody Targets Zinc Transporter-8 (ZnT8) for in vivo beta-Cell Imaging and Islet-Specific Therapies.
    Diabetes. 2022 Nov 30:db220477. doi: 10.2337/db22-0477.
    PubMed     Abstract available
    
    
    
39. DERR AG, Arowosegbe A, Satish B, Redick SD, et al
    An Early Islet Transcriptional Signature is Associated with Local Inflammation in Autoimmune Diabetes.
    Diabetes. 2022 Nov 8. pii: 147854. doi: 10.2337/db22-0521.
    PubMed     Abstract available
    
    
    
40. TANG X, Wang J, Abboud HE, Chen Y, et al
    Sustained Upregulation of Endothelial Nox4 Mediates Retinal Vascular Pathology in Type 1 Diabetes.
    Diabetes. 2022 Nov 2. pii: 147850. doi: 10.2337/db22-0194.
    PubMed     Abstract available
    
    
    
41. NG XW, Chung YH, Asadi F, Kong C, et al
    RhoA as a Signaling Hub Controlling Glucagon Secretion From Pancreatic alpha-Cells.
    Diabetes. 2022;71:2384-2394.
    PubMed     Abstract available
    
    
    October 2022
42. GUYER P, Arribas-Layton D, Manganaro A, Speake C, et al
    Recognition of mRNA Splice Variant and Secretory Granule Epitopes by CD4+ T Cells in Type 1 Diabetes.
    Diabetes. 2022 Oct 6. pii: 147715. doi: 10.2337/db22-0191.
    PubMed     Abstract available
    
    
    
43. CORKEY BE, Kilpatrick LE, Evans-Molina C
    Hypothesis: Induction of Autoimmunity in Type 1 Diabetes-A Lipid Focus.
    Diabetes. 2022;71:2067-2074.
    PubMed     Abstract available
    
    
    September 2022
44. KWON BC, Achenbach P, Anand V, Frohnert BI, et al
    Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals with Presymptomatic Type 1 Diabetes.
    Diabetes. 2022 Sep 16. pii: 147551. doi: 10.2337/db22-0360.
    PubMed     Abstract available
    
    
    
45. SHARMA A, Misra-Hebert AD, Mariam A, Milinovich A, et al
    Impacts of COVID-19 on Glycemia and Risk of Diabetic Ketoacidosis.
    Diabetes. 2022 Sep 15. pii: 147590. doi: 10.2337/db22-0264.
    PubMed     Abstract available
    
    
    
46. SOOKAROMDEE P, Wiwanitkit V
    Comment on D'Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800-1806.
    Diabetes. 2022;71:e13.
    PubMed    
    
    
    
47. D'ADDIO F, Fiorina P
    Response to Comment on D'Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800-1806.
    Diabetes. 2022;71:e14.
    PubMed    
    
    
    August 2022
48. CRAWFORD SA, Wiles TA, Wenzlau JM, Powell RL, et al
    Cathepsin D Drives the Formation of Hybrid Insulin Peptides Relevant to the Pathogenesis of Type 1 Diabetes.
    Diabetes. 2022 Aug 30. pii: 147526. doi: 10.2337/db22-0303.
    PubMed     Abstract available
    
    
    
49. MALLONE R, Halliez C, Rui J, Herold KC, et al
    The beta-Cell in Type 1 Diabetes Pathogenesis: A Victim of Circumstances or an Instigator of Tragic Events?
    Diabetes. 2022;71:1603-1610.
    PubMed     Abstract available
    
    
    June 2022
50. CORVILLO F, Abel BS, Lopez-Lera A, Ceccarini G, et al
    Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients with Acquired Generalized Lipodystrophy.
    Diabetes. 2022 Jun 30. pii: 147153. doi: 10.2337/db21-1086.
    PubMed     Abstract available
    
    
    
51. CHEN M, Hu R, Cavinato C, Zhuang ZW, et al
    Fibronectin-integrin alpha5 signaling in vascular complications of type 1 diabetes.
    Diabetes. 2022 Jun 30. pii: 147154. doi: 10.2337/db21-0958.
    PubMed     Abstract available
    
    
    
52. ITO Y, Sun R, Yagimuma H, Taki K, et al
    Protein Tyrosine Phosphatase 1B Deficiency Improves Glucose Homeostasis in Insulin-Dependent Diabetes Mellitus Treated with Leptin.
    Diabetes. 2022 Jun 24. pii: 147141. doi: 10.2337/db21-0953.
    PubMed     Abstract available
    
    
    
53. MEI-LING Y, Sean E C, Renelle G, TuKiet T L, et al
    Carbonyl Post-Translational Modification Associated with Early Onset Type 1 Diabetes Autoimmunity.
    Diabetes. 2022 Jun 22. pii: 147120. doi: 10.2337/db21-0989.
    PubMed     Abstract available
    
    
    
54. CARRY PM, Waugh K, Vanderlinden LA, Johnson RK, et al
    Changes in the Co-Expression of Innate Immunity Genes During Persistent Islet Autoimmunity are Associated with Progression of Islet Autoimmunity: The Diabetes Autoimmunity Study in the Young (DAISY).
    Diabetes. 2022 Jun 20. pii: 147107. doi: 10.2337/db21-1111.
    PubMed     Abstract available
    
    
    
55. LEUNG SS, Borg DJ, McCarthy DA, Boursalian TE, et al
    Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells.
    Diabetes. 2022 Jun 17. pii: 147090. doi: 10.2337/db22-0177.
    PubMed     Abstract available
    
    
    
56. MACDONALD MJ, Ansari IH, Riedemann AS, Stoker SW, et al
    A Novel Intron-Encoded Neuropilin-1 Isoform in Pancreatic Islets Associated With Very Young Age of Onset of Type 1 Diabetes.
    Diabetes. 2022 Jun 17. pii: 147085. doi: 10.2337/db21-1070.
    PubMed     Abstract available
    
    
    
57. MANDEL-BREHM C, Vazquez SE, Liverman C, Cheng M, et al
    Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy.
    Diabetes. 2022 Jun 16. pii: 147096. doi: 10.2337/db21-1172.
    PubMed     Abstract available
    
    
    May 2022
58. LIN Y, Perovanovic J, Kong Y, Igyarto BZ, et al
    Antibody-Mediated Targeting of a Hybrid-Insulin-Peptide Towards Neonatal Thymic Langerin+ Cells Enhances T Cell Central Tolerance and Delays Autoimmune Diabetes.
    Diabetes. 2022 May 27. pii: 147050. doi: 10.2337/db21-1069.
    PubMed     Abstract available
    
    
    
59. BAKER NL, Hammad SM, Hunt KJ, Semler A, et al
    Plasma ApoM levels and Progression to Kidney Dysfunction in Type 1 Diabetics.
    Diabetes. 2022 May 12. pii: 146945. doi: 10.2337/db21-0920.
    PubMed     Abstract available
    
    
    
60. D'ADDIO F, Sabiu G, Usuelli V, Assi E, et al
    Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes.
    Diabetes. 2022 May 12. pii: 146944. doi: 10.2337/db22-0053.
    PubMed     Abstract available
    
    
    
61. CARR ALJ, Inshaw JRJ, Flaxman CS, Leete P, et al
    Circulating C-Peptide Levels in Living Children and Young People and Pancreatic Beta Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration.
    Diabetes. 2022 May 2. pii: 146866. doi: 10.2337/db22-0097.
    PubMed     Abstract available
    
    
    
62. YIP L, Alkhataybeh R, Taylor C, Fuhlbrigge R, et al
    Identification of Novel Disease-Relevant Genes and Pathways in the Pathogenesis of Type 1 Diabetes: A Potential Defect in Pancreatic Iron Homeostasis.
    Diabetes. 2022 May 2. pii: 146861. doi: 10.2337/db21-0948.
    PubMed     Abstract available
    
    
    
63. JING Y, Kong Y, McGinty J, Blahnik-Fagan G, et al
    T-Cell Receptor/HLA Humanized Mice Reveal Reduced Tolerance and Increased Immunogenicity of Posttranslationally Modified GAD65 Epitope.
    Diabetes. 2022;71:1012-1022.
    PubMed     Abstract available
    
    
    April 2022
64. SIMS EK, Besser REJ, Dayan C, Geno Rasmussen C, et al
    Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective.
    Diabetes. 2022;71:610-623.
    PubMed     Abstract available
    
    
    March 2022
65. PIETROPAOLO M, Hotez P, Giannoukakis N
    Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS CoV-2-Infected Young Individuals: Is it Type 1 Diabetes?
    Diabetes. 2022 Mar 16. pii: 144830. doi: 10.2337/db21-0831.
    PubMed     Abstract available
    
    
    
66. DI PAOLA R, Marucci A, Trischitta V
    The Need to Increase Clinical Skills and Change the Genetic Testing Strategy for Monogenic Diabetes.
    Diabetes. 2022;71:379-380.
    PubMed    
    
    
    January 2022
67. LIU YF, Powrie J, Arif S, Yang JHM, et al
    Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple beta-Cell Peptides in Type 1 Diabetes.
    Diabetes. 2022 Jan 24. pii: 140961. doi: 10.2337/db21-0728.
    PubMed     Abstract available
    
    
    
68. BROOKS-WORRELL B, Hampe CS, Hattery EG, Palomino B, et al
    Islet Autoimmunity is Highly Prevalent and Associated With Diminished beta-Cell Function in Patients With Type 2 Diabetes in the Grade Study.
    Diabetes. 2022 Jan 21. pii: 140947. doi: 10.2337/db21-0590.
    PubMed     Abstract available
    
    
    
69. ELVIRA B, Vandenbempt V, Bauza-Martinez J, Crutzen R, et al
    PTPN2 Regulates the Interferon Signaling and Endoplasmic Reticulum Stress Response in Pancreatic beta-Cells in Autoimmune Diabetes.
    Diabetes. 2022 Jan 14. pii: 139308. doi: 10.2337/db21-0443.
    PubMed     Abstract available
    
    
    
70. LOCKER KCS, Kachapati K, Wu Y, Bednar KJ, et al
    Endosomal Sequestration of TLR4 Antibody Induces Myeloid-Derived Suppressor Cells and Reverses Acute Type 1 Diabetes.
    Diabetes. 2022 Jan 14. pii: 139245. doi: 10.2337/db21-0426.
    PubMed     Abstract available
    
    
    
71. CHEN X, Li Y, Yuan X, Yuan W, et al
    Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting beta-Catenin Degradation in Type 1 Diabetic Mice.
    Diabetes. 2022 Jan 14. pii: 139251. doi: 10.2337/db21-0506.
    PubMed     Abstract available
    
    
    
72. JAMISON BL, DiLisio JE, Beard KS, Neef T, et al
    Tolerogenic Delivery of a Hybrid Insulin Peptide Markedly Prolongs Islet Graft Survival in the Non-Obese Diabetic (NOD) Mouse.
    Diabetes. 2022 Jan 7. pii: 139243. doi: 10.2337/db20-1170.
    PubMed     Abstract available
    
    
    
73. BEDIAGA NG, Garnham AL, Naselli G, Bandala-Sanchez E, et al
    Cytotoxicity-related gene expression and chromatin accessibility define a subset of CD4+ T cells that mark progression to type 1 diabetes.
    Diabetes. 2022 Jan 7. pii: 139244. doi: 10.2337/db21-0612.
    PubMed     Abstract available
    
    
    December 2021
74. BOEDER SC, Gregory JM, Giovannetti ER, Pettus JH, et al
    SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants with Type 1 Diabetes.
    Diabetes. 2021 Dec 2. pii: db21-0769. doi: 10.2337/db21-0769.
    PubMed     Abstract available
    
    
    
75. PANZER JK, Caicedo A
    Targeting the Pancreatic alpha-Cell to Prevent Hypoglycemia in Type 1 Diabetes.
    Diabetes. 2021;70:2721-2732.
    PubMed     Abstract available
    
    
    November 2021
76. SMITH MJ, Pastor L, Newman JRB, Concannon P, et al
    Genetic Control of Splicing at SIRPG Modulates Risk of Type 1 Diabetes.
    Diabetes. 2021 Nov 19. pii: db21-0194. doi: 10.2337/db21-0194.
    PubMed     Abstract available
    
    
    
77. CHARLES MA, Leslie RD
    Diabetes: Concepts of beta-Cell Organ Dysfunction and Failure Would Lead to Earlier Diagnoses and Prevention.
    Diabetes. 2021;70:2444-2456.
    PubMed     Abstract available
    
    
    
78. SHARMA RB, Landa-Galvan HV, Alonso LC
    Living Dangerously: Protective and Harmful ER Stress Responses in Pancreatic beta-Cells.
    Diabetes. 2021;70:2431-2443.
    PubMed     Abstract available
    
    
    October 2021
79. VECCHIONE A, Jofra T, Gerosa J, Shankwitz K, et al
    Reduced Follicular Regulatory T Cells in Spleen and Pancreatic Lymph Nodes of Patients With Type 1 Diabetes.
    Diabetes. 2021 Oct 7. pii: db21-0091. doi: 10.2337/db21-0091.
    PubMed     Abstract available
    
    
    
80. RUSS HA, Davidson HW
    Found in Translation: Novel Insights Into Type 1 Diabetes and beta-Cell Biology.
    Diabetes. 2021;70:2185-2186.
    PubMed    
    
    
    
81. THOMAIDOU S, Slieker RC, van der Slik AR, Boom J, et al
    Long RNA Sequencing and Ribosome Profiling of Inflamed beta-Cells Reveal an Extensive Translatome Landscape.
    Diabetes. 2021;70:2299-2312.
    PubMed     Abstract available
    
    
    September 2021
82. AZOURY ME, Samassa F, Buitinga M, Nigi L, et al
    CD8+ T cells variably recognize native versus citrullinated GRP78 epitopes in type 1 diabetes.
    Diabetes. 2021 Sep 24. pii: db21-0259. doi: 10.2337/db21-0259.
    PubMed     Abstract available
    
    
    
83. OH E, McCown EM, Ahn M, Garcia PA, et al
    Syntaxin 4 enrichment in beta-cells prevents conversion to autoimmune diabetes in non-obese diabetic (NOD) mice.
    Diabetes. 2021 Sep 23. pii: db21-0170. doi: 10.2337/db21-0170.
    PubMed     Abstract available
    
    
    
84. SIMS EK, Cuthbertson D, Herold KC, Sosenko JM, et al
    The Deterrence of Rapid Metabolic Decline within 3 Months after Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes.
    Diabetes. 2021 Sep 22. pii: db21-0519. doi: 10.2337/db21-0519.
    PubMed     Abstract available
    
    
    
85. SRIVASTAVA N, Hu H, Vomund AN, Peterson OJ, et al
    Chromogranin A Deficiency Confers Protection from Autoimmune Diabetes Via Multiple Mechanisms.
    Diabetes. 2021 Sep 8. pii: db21-0513. doi: 10.2337/db21-0513.
    PubMed     Abstract available
    
    
    
86. STONE VM, Butrym M, Hankaniemi MM, Sioofy-Khojine AB, et al
    Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect.
    Diabetes. 2021 Sep 8. pii: db21-0193. doi: 10.2337/db21-0193.
    PubMed     Abstract available
    
    
    August 2021
87. EIZIRIK DL, Szymczak F, Alvelos MI, Martin F, et al
    From Pancreatic beta-Cell Gene Networks to Novel Therapies for Type 1 Diabetes.
    Diabetes. 2021 Aug 20. pii: dbi20-0046. doi: 10.2337/dbi20-0046.
    PubMed     Abstract available
    
    
    
88. PAGNI PP, Chaplin J, Wijaranakula M, Wesley JD, et al
    Multicomponent Plasmid Protects Mice From Spontaneous Autoimmune Diabetes.
    Diabetes. 2021 Aug 13. pii: db21-0327. doi: 10.2337/db21-0327.
    PubMed     Abstract available
    
    
    
89. PAGNI PP, Chaplin J, Wijaranakula M, Wesley JD, et al
    Multicomponent Plasmid Protects Mice From Spontaneous Autoimmune Diabetes.
    Diabetes. 2021 Aug 13. pii: 139085. doi: 10.2337/db21-0327.
    PubMed     Abstract available
    
    
    
90. YANG D, Patel S, Szlachcic WJ, Chmielowiec J, et al
    Pancreatic differentiation of stem cells reveals pathogenesis of a syndrome of Ketosis-Prone Diabetes.
    Diabetes. 2021 Aug 3. pii: db20-1293. doi: 10.2337/db20-1293.
    PubMed     Abstract available
    
    
    July 2021
91. DAHLSTROM EH, Saksi J, Forsblom C, Uglebjerg N, et al
    The low-expression variant of FABP4 is associated with cardiovascular disease in type 1 diabetes.
    Diabetes. 2021 Jul 9. pii: db21-0056. doi: 10.2337/db21-0056.
    PubMed     Abstract available
    
    
    
92. WANG Y, Niu A, Pan Y, Cao S, et al
    Profile of podocyte translatome during development of type 2 and type 1 diabetic nephropathy using podocyte-specific TRAP mRNA RNA-seq.
    Diabetes. 2021 Jul 7. pii: db21-0110. doi: 10.2337/db21-0110.
    PubMed     Abstract available
    
    
    June 2021
93. LERNMARK A
    Etiology of Autoimmune Islet Disease: Timing Is Everything.
    Diabetes. 2021 Jun 21. pii: dbi18-0034. doi: 10.2337/dbi18-0034.
    PubMed     Abstract available
    
    
    
94. DASAN MC, Sandireddy R, Bogireddy H, Tee N, et al
    Cardiac Tissue Factor Regulates Inflammation, Hypertrophy and Heart Failure in Mouse Model of Type 1 Diabetes.
    Diabetes. 2021 Jun 21. pii: db20-0719. doi: 10.2337/db20-0719.
    PubMed     Abstract available
    
    
    
95. NIMKULRAT SD, Bernstein MN, Ni Z, Brown J, et al
    The Anna Karenina Model of beta-Cell Maturation in Development and Their Dedifferentiation in Type 1 and Type 2 Diabetes.
    Diabetes. 2021 Jun 15. pii: db21-0211. doi: 10.2337/db21-0211.
    PubMed     Abstract available
    
    
    May 2021
96. GALINDO-ALBARRAN A, Castan S, Santamaria JC, Joffre OP, et al
    The repertoire of newly developing regulatory T cells in the type I diabetes-prone NOD mouse is very diverse.
    Diabetes. 2021 May 25. pii: db20-1072. doi: 10.2337/db20-1072.
    PubMed     Abstract available
    
    
    
97. HILLER H, Beachy DE, Lebowitz JJ, Engler S, et al
    Monogenic Diabetes and Integrated Stress Response Genes Display Altered Gene Expression in Type 1 Diabetes.
    Diabetes. 2021 May 25. pii: db21-0070. doi: 10.2337/db21-0070.
    PubMed     Abstract available
    
    
    
98. JAHOOR F, Hsu JW, Mehta PB, Keene KR, et al
    Metabolomic profiling of patients with A-beta+ Ketosis-Prone Diabetes during diabetic ketoacidosis.
    Diabetes. 2021 May 21. pii: db21-0066. doi: 10.2337/db21-0066.
    PubMed     Abstract available
    
    
    
99. MALLONE R, You S
    The SAgA of Antigen-Specific Immunotherapy for Type 1 Diabetes.
    Diabetes. 2021 May 20. pii: dbi21-0011. doi: 10.2337/dbi21-0011.
    PubMed    
    
    
    
100. BETTINI M, Bettini ML
     Function, Failure, and the Future Potential of Tregs in Type 1 Diabetes.
     Diabetes. 2021 May 20. pii: dbi18-0058. doi: 10.2337/dbi18-0058.
     PubMed     Abstract available
     
     
     
101. BRITTEN-JONES AC, Kamel JT, Roberts LJ, Braat S, et al
     Investigating the neuroPRotective effect of Oral Omega-3 Fatty acid Supplementation in type 1 diabetes (nPROOFS1): a randomised, placebo-controlled trial.
     Diabetes. 2021 May 5. pii: db21-0136. doi: 10.2337/db21-0136.
     PubMed     Abstract available
     
     
     
102. RODRIGUEZ-CALVO T, Chen YC, Verchere CB, Haataja L, et al
     Altered beta-Cell Prohormone Processing and Secretion in Type 1 Diabetes.
     Diabetes. 2021 May 4. pii: dbi20-0034. doi: 10.2337/dbi20-0034.
     PubMed     Abstract available
     
     
     
103. GREENBAUM CJ
     A Key to T1D Prevention: Screening and Monitoring Relatives as Part of Clinical Care.
     Diabetes. 2021;70:1029-1037.
     PubMed     Abstract available
     
     
     April 2021
104. CARRY P, Vanderlinden LA, Johnson RK, Buckner T, et al
     Phospholipid Levels at Seroconversion are Associated with Resolution of Persistent Islet Autoimmunity: The Diabetes Autoimmunity Study in the Young.
     Diabetes. 2021 Apr 16. pii: db20-1251. doi: 10.2337/db20-1251.
     PubMed     Abstract available
     
     
     
105. LINSLEY PS, Greenbaum CJ, Nepom GT
     Uncovering Pathways to Personalized Therapies in Type 1 Diabetes.
     Diabetes. 2021;70:831-841.
     PubMed     Abstract available
     
     
     March 2021
106. FORBES JM, McCarthy DA, Kassianos AJ, Baskerville T, et al
     T-Cell Expression and Release of Kidney Injury Molecule-1 in Response to Glucose Variations Initiates Kidney Injury in Early Diabetes.
     Diabetes. 2021 Mar 18. pii: db20-1081. doi: 10.2337/db20-1081.
     PubMed     Abstract available
     
     
     
107. BAGGER JI, Grondahl M, Lund A, Holst JJ, et al
     Glucagonostatic Potency of GLP-1 in Patients with Type 2 Diabetes, in Patients with Type 1 Diabetes and in Healthy Controls.
     Diabetes. 2021 Mar 15. pii: db20-0998. doi: 10.2337/db20-0998.
     PubMed     Abstract available
     
     
     February 2021
108. HALLER MJ, Jacobsen LM, Posgai AL, Schatz DA, et al
     How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?
     Diabetes. 2021 Feb 25. pii: dbi20-0045. doi: 10.2337/dbi20-0045.
     PubMed     Abstract available
     
     
     
109. LIN A, Mack JA, Bruggeman B, Jacobsen LM, et al
     Low-dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report.
     Diabetes. 2021 Feb 25. pii: db20-1103. doi: 10.2337/db20-1103.
     PubMed     Abstract available
     
     
     
110. HERDER C, Maalmi H, Strassburger K, Zaharia OP, et al
     Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes.
     Diabetes. 2021 Feb 19. pii: db20-1054. doi: 10.2337/db20-1054.
     PubMed     Abstract available
     
     
     
111. BOLDISON J, Thayer TC, Davies J, Wong FS, et al
     Natural Protection From Type 1 Diabetes in Non Obese Diabetic (Nod) Mice is Characterised by a Unique Pancreatic Islet Phenotype.
     Diabetes. 2021 Feb 2. pii: db20-0945. doi: 10.2337/db20-0945.
     PubMed     Abstract available
     
     
     
112. GLIEBERMAN AL, Pope BD, Melton DA, Parker KK, et al
     Building Biomimetic Potency Tests for Islet Transplantation.
     Diabetes. 2021;70:347-363.
     PubMed     Abstract available
     
     
     
113. PETRELLI A, Atkinson MA, Pietropaolo M, Giannoukakis N, et al
     Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes.
     Diabetes. 2021;70:313-322.
     PubMed     Abstract available
     
     
     January 2021
114. ESPES D, Carlsson PO, Selvaraju RK, Rosestedt M, et al
     Longitudinal Assessment of (11)C-5-Hydroxytryptophan Uptake in Pancreas After Debut of Type 1 Diabetes.
     Diabetes. 2021 Jan 21. pii: db20-0776. doi: 10.2337/db20-0776.
     PubMed     Abstract available
     
     
     
115. MHANNA V, Fourcade G, Barennes P, Quiniou V, et al
     Impaired Activated/Memory Regulatory T Cell Clonal Expansion Instigates Diabetes in NOD Mice.
     Diabetes. 2021 Jan 21. pii: db20-0896. doi: 10.2337/db20-0896.
     PubMed     Abstract available
     
     
     
116. ROSS JJ, Wasserfall CH, Bacher R, Perry DJ, et al
     Exocrine Pancreatic Enzymes Are a Serological Biomarker for Type 1 Diabetes Staging and Pancreas Size.
     Diabetes. 2021 Jan 13. pii: db20-0995. doi: 10.2337/db20-0995.
     PubMed     Abstract available
     
     
     
117. HAUKKA J, Sandholm N, Valo E, Forsblom C, et al
     Novel Linkage Peaks Discovered for Diabetic Nephropathy in Individuals With Type 1 Diabetes.
     Diabetes. 2021 Jan 7. pii: db20-0158. doi: 10.2337/db20-0158.
     PubMed     Abstract available
     
     
     
118. RODRIGUEZ-CALVO T, Krogvold L, Amirian N, Dahl-Jorgensen K, et al
     One in Ten CD8+ Cells in the Pancreas of Living Individuals With Recent Onset Type 1 Diabetes Recognizes the Preproinsulin Epitope PPI15-24.
     Diabetes. 2021 Jan 7. pii: db20-0908. doi: 10.2337/db20-0908.
     PubMed     Abstract available
     
     
     December 2020
119. SNOWHITE I, Pastori R, Sosenko J, Cayetano SM, et al
     Baseline Assessment of Circulating microRNAs Near Diagnosis of Type 1 Diabetes Predicts Future Stimulated Insulin Secretion.
     Diabetes. 2020 Dec 4. pii: db20-0817. doi: 10.2337/db20-0817.
     PubMed     Abstract available
     
     
     November 2020
120. SODRE FMC, Bissenova S, Bruggeman Y, Tilvawala R, et al
     Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice.
     Diabetes. 2020 Nov 17. pii: db20-0421. doi: 10.2337/db20-0421.
     PubMed     Abstract available
     
     
     
121. FLOYEL T, Meyerovich K, Prause MC, Kaur S, et al
     SKAP2, a Candidate Gene for Type 1 Diabetes, Regulates beta-Cell Apoptosis and Glycaemic Control in Newly Diagnosed Patients.
     Diabetes. 2020 Nov 17. pii: db20-0092. doi: 10.2337/db20-0092.
     PubMed     Abstract available
     
     
     
122. SHA S, Pearson JA, Peng J, Hu Y, et al
     TLR9-Deficiency in B Cells Promotes Immune Tolerance via IL-10 in a Type 1 Diabetes Mouse Model.
     Diabetes. 2020 Nov 5. pii: db20-0373. doi: 10.2337/db20-0373.
     PubMed     Abstract available
     
     
     October 2020
123. RUSSO F, Citro A, Squeri G, Sanvito F, et al
     InsB9-23 Gene Transfer To Hepatocytes-Based Combined Therapy Abrogates Recurrence of Type-1 Diabetes After Islet Transplantation.
     Diabetes. 2020 Oct 29. pii: db19-1249. doi: 10.2337/db19-1249.
     PubMed     Abstract available
     
     
     
124. THAYER TC, Davies J, Pearson JA, Hanna SJ, et al
     Differentiating MHC-Dependent and -Independent Mechanisms of Lymph Node Stromal Cell Regulation of Proinsulin-Specific CD8(+) T-Cells in type 1 Diabetes.
     Diabetes. 2020 Oct 29. pii: db19-1050. doi: 10.2337/db19-1050.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.